UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis

Journal of clinical oncology, 2008-07, Vol.26 (20), p.3358-3363

2008

Volltextzugriff (PDF)

Single-cell analysis based dissection of clonality in myelofibrosis

Nature communications, 2020-01, Vol.11 (1), p.73-73, Article 73

2020

Volltextzugriff (PDF)

European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor

Blood, 2008-12, Vol.112 (12), p.4437-4444

2008

Volltextzugriff (PDF)

Advanced Therapy Medicinal Products' Translation in Europe: A Developers' Perspective

Frontiers in medicine, 2022-02, Vol.9, p.757647-757647

2022

Volltextzugriff (PDF)

Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective

Frontiers in cell and developmental biology, 2023-01, Vol.10, p.1081644-1081644

2023

Volltextzugriff (PDF)

Finding of Kinase Domain Mutations in Patients With Chronic Phase Chronic Myeloid Leukemia Responding to Imatinib May Identify Those at High Risk of Disease Progression

Journal of clinical oncology, 2008-10, Vol.26 (29), p.4806-4813

2008

Volltextzugriff (PDF)

How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet

Haematologica (Roma), 2009-08, Vol.94 (8), p.1135-1150

2009

Volltextzugriff (PDF)

In vivo kinetics of kinase domain mutations in CML patients treated with dasatinib after failing imatinib

Blood, 2008-02, Vol.111 (4), p.2378-2381

2008

Volltextzugriff (PDF)

Interferon-α or homoharringtonine as salvage treatment for chronic myeloid leukemia patients who acquire the T315I BCR-ABL mutation

Blood, 2007-10, Vol.110 (7), p.2779-2780

2007

Volltextzugriff (PDF)

Low-Dose Interleukin-2 Therapy: Fine-tuning Treg in Solid Organ Transplantation?

Transplantation, 2024-07

2024

Volltextzugriff (PDF)

Phase I/II trial of adding semisynthetic homoharringtonine in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response on imatinib

Cancer, 2005-05, Vol.103 (9), p.1850-1855

2005

Volltextzugriff (PDF)

Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

Blood, 2000-10, Vol.96 (8), p.2712-2716

2000

Volltextzugriff (PDF)

GFI136N as a therapeutic and prognostic marker for myelodysplastic syndrome (MDS)

Experimental hematology, 2016-07, Vol.44 (7), p.590-595.e1

2016

Volltextzugriff (PDF)

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase–polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

Blood, 2001-03, Vol.97 (6), p.1560-1565

2001

Volltextzugriff (PDF)

Detection of Wilms' Tumor Antigen–Specific CTL in Tumor-Draining Lymph Nodes of Patients with Early Breast Cancer

Clinical cancer research, 2006-01, Vol.12 (1), p.34-42

2006

Volltextzugriff (PDF)

High Prevalence of Hemoglobin Disorders and Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in the Republic of Guinea (West Africa)

Hemoglobin, 2012-02, Vol.36 (1), p.25-37

2012

Volltextzugriff (PDF)

Frequency of Major Molecular Responses to Imatinib or Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic Myeloid Leukemia

The New England journal of medicine, 2003-10, Vol.349 (15), p.1423-1432

2003

Volltextzugriff (PDF)

Droplet Digital PCR Reliably Detects a Single Copy of BCR-ABL1

Blood, 2015-12, Vol.126 (23), p.2784-2784

2015

Volltextzugriff (PDF)

Single-Cell Analysis Based Dissection of Clonality in Myelofibrosis

Blood, 2019-11, Vol.134 (Supplement_1), p.469-469

2019

Volltextzugriff (PDF)

BCL-6: rearrangement and mutation in lymphoma

Methods in molecular medicine, 2005, Vol.115, p.251

2005

Volltextzugriff (PDF)

MSI2 and TGFβR1 Expression Levels in CML Patients and Hematopoietic Cell Lines

Blood, 2014-12, Vol.124 (21), p.4533-4533

2014

Volltextzugriff (PDF)

BCR-ABL Transcript Dynamics Support the Hypothesis That Leukemic Stem Cells Are Reduced during Imatinib Treatment

Clinical cancer research, 2011-11, Vol.17 (21), p.6812-6821

2011

Volltextzugriff (PDF)

Clinical and haematological consequences of recurrent G6PD mutations and a single new mutation causing chronic nonspherocytic haemolytic anaemia

British journal of haematology, 1998-06, Vol.101 (4), p.670-675

1998

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Englisch
(87)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Humans
(43)
Life Sciences & Biomedicine
(43)
Hematology
(32)
Biological And Medical Sciences
(25)
Female
(24)
Male
(24)
Medical Sciences
(24)
Middle Aged
(23)
Adult
(20)
Hematologic And Hematopoietic Diseases
(19)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics
(18)
Fusion Proteins, Bcr-Abl - Genetics
(17)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(17)
Aged
(16)
Imatinib Mesylate
(14)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(14)
Benzamides
(13)
Mutation
(12)
Oncology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)

Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis

Single-cell analysis based dissection of clonality in myelofibrosis

European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor

Advanced Therapy Medicinal Products' Translation in Europe: A Developers' Perspective

Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective

Finding of Kinase Domain Mutations in Patients With Chronic Phase Chronic Myeloid Leukemia Responding to Imatinib May Identify Those at High Risk of Disease Progression

How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet

In vivo kinetics of kinase domain mutations in CML patients treated with dasatinib after failing imatinib

Interferon-α or homoharringtonine as salvage treatment for chronic myeloid leukemia patients who acquire the T315I BCR-ABL mutation

Low-Dose Interleukin-2 Therapy: Fine-tuning Treg in Solid Organ Transplantation?

Phase I/II trial of adding semisynthetic homoharringtonine in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response on imatinib

Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

GFI136N as a therapeutic and prognostic marker for myelodysplastic syndrome (MDS)

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase–polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

Detection of Wilms' Tumor Antigen–Specific CTL in Tumor-Draining Lymph Nodes of Patients with Early Breast Cancer

High Prevalence of Hemoglobin Disorders and Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in the Republic of Guinea (West Africa)

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

Frequency of Major Molecular Responses to Imatinib or Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic Myeloid Leukemia

Droplet Digital PCR Reliably Detects a Single Copy of BCR-ABL1

Single-Cell Analysis Based Dissection of Clonality in Myelofibrosis

BCL-6: rearrangement and mutation in lymphoma

MSI2 and TGFβR1 Expression Levels in CML Patients and Hematopoietic Cell Lines

BCR-ABL Transcript Dynamics Support the Hypothesis That Leukemic Stem Cells Are Reduced during Imatinib Treatment

Clinical and haematological consequences of recurrent G6PD mutations and a single new mutation causing chronic nonspherocytic haemolytic anaemia

Suchergebnisse filtern